Lary CW, Rosen CJ, Kiel DP. Osteoporosis and Dementia: Establishing a Link. J Bone Miner Res. 2021.
Lary CW, Hinton AC, Nevola KT, Shireman TI, Motyl KJ, Houseknecht KL, et al. Association of Beta Blocker Use With Bone Mineral Density in the Framingham Osteoporosis Study: A Cross-Sectional Study. JBMR Plus. 2020;4(9):e10388.
Nevola KT, Kiel DP, Zullo AR, Weiss S, Homuth G, Foessl I, et al. miRNA Mechanisms Underlying the Association of Beta Blocker Use and Bone Mineral Density. J Bone Miner Res. 2020.
Nevola KT, Nagarajan A, Hinton AC, Trajanoska K, Formosa MM, Xuereb-Anastasi A, et al. Pharmacogenomic effects of β-blocker use on femoral neck bone mineral density. Journal of the Endocrine Society. 2021.
Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks P, et al. Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol Biomarkers Prev. 2014;23(1):117-25.
Duarte CW, Black AW, Lucas FL, Vary CP. Cancer incidence in patients with hereditary hemorrhagic telangiectasia. J Cancer Res Clin Oncol. 2016.
Duarte CW, Lindner V, Francis S, Schoormans D. Visualization of cancer and cardiovascular disease co-occurrence using network methods. Journal of Clinical Oncology/Clinical Cancer Informatics. 2017.
Duarte CW, Black A, Murray K, Haskins A, Lucas L, Hallen S, et al. Validation of the Patient-Reported Outcome Mortality Prediction Tool (PROMPT). Journal of Pain and Symptom Management. 2015.
Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, et al. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS One. 2012;7(1):e29653.
Cosgun E, Limdi NA, Duarte CW. High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans. Bioinformatics. 2011;27(10):1384-9.